Beijing Aosaikang Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of active pharmaceutical ingredients and formulations in C...
ASK PHARM released its performance for the first three quarters, with a net profit attributable to the parent company of 223 million yuan, a year-on-year increase of 75.81%
Aosaikang: Innovative drug ASKB589 will announce clinical research data at the 2025 ESMO Annual Meeting
Aosaikang's subsidiary signs ASKG712 project licensing agreement
The pharmaceutical sector fell at the beginning of trading, with SUNFLOWER dropping 10%
The pharmaceutical sector fluctuates and strengthens, ASK PHARM hits the limit up
ASK PHARM: Innovative drug ASKC202 completes first patient dosing in Phase III registration clinical study